Sanofi celebrates 50th anniversary of France – China relations

Sanofi (EURONEXT: SAN and NYSE: SNY) announced today its participation in the commemoration of the 50th anniversary of diplomatic relations between France and the People’s Republic of China. In supporting the celebration, Sanofi affirms its commitment to economic development and public health in China. 

“As one of the first multinational pharmaceutical companies to operate in China, Sanofi has continually provided innovative healthcare solutions for patients, expanding in pace with the country’s development,” said Christopher A. Viehbacher, Chief Executive Officer, Sanofi. “Our expanding portfolio of medicines and vaccines allows us to contribute to important public health issues in China, such as chronic disease management, prevention and food safety.”

As one of the commemoration’s major sponsors, Sanofi will participate in scientific events throughout the year in France and China, which will include Chinese students from select academic institutions in France. Sanofi also plans to participate in the “Better Healthcare” conference in Beijing with “Club Santé Chine”, an initiative by the French government to help small and medium enterprises export healthcare products.

China is a showcase for Sanofi’s collaborative approach, with many research and development agreements signed in the past six years, including in the areas of cancer, stem cells, diabetes and aging diseases. Sanofi partners include Shanghai Institutes for Biological Sciences, the Tianjin Institute of Hematology and Peking University. In recognition of the richness of China’s research ecosystem, Sanofi settled management of its Asia-Pacific research and development activities in China in 2011.